• Consensus Rating: Hold
  • Consensus Price Target: $48.78
  • Forecasted Upside: 22.39%
  • Number of Analysts: 9
  • Breakdown:
  • 0 Sell Ratings
  • 5 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
$39.85
▼ -0.206 (-0.51%)

This chart shows the closing price for QGEN by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Qiagen Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for QGEN and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for QGEN

Analyst Price Target is $48.78
▲ +22.39% Upside Potential
This price target is based on 9 analysts offering 12 month price targets for Qiagen in the last 3 months. The average price target is $48.78, with a high forecast of $52.50 and a low forecast of $43.75. The average price target represents a 22.39% upside from the last price of $39.85.

This chart shows the closing price for QGEN for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 9 polled investment analysts is to hold stock in Qiagen. This rating changed within the last month from a Moderate Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 0 sell ratings
8/26/2023
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
11/24/2023
  • 0 strong buy ratings
  • 5 buy ratings
  • 3 hold ratings
  • 0 sell ratings
2/22/2024
  • 0 strong buy ratings
  • 5 buy ratings
  • 4 hold ratings
  • 0 sell ratings
5/22/2024
  • 0 strong buy ratings
  • 6 buy ratings
  • 3 hold ratings
  • 0 sell ratings
8/20/2024
  • 0 strong buy ratings
  • 6 buy ratings
  • 4 hold ratings
  • 0 sell ratings
11/18/2024
  • 0 strong buy ratings
  • 5 buy ratings
  • 4 hold ratings
  • 0 sell ratings
1/17/2025
  • 0 strong buy ratings
  • 4 buy ratings
  • 5 hold ratings
  • 0 sell ratings
2/16/2025

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 5 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
2/7/2025UBS GroupLower TargetNeutral ➝ Neutral$50.00 ➝ $48.00
1/6/2025Morgan StanleyReiterated RatingOverweight ➝ Equal Weight$48.61 ➝ $46.67
12/10/2024Jefferies Financial GroupReiterated RatingHold ➝ Buy$40.83 ➝ $52.50
10/17/2024Hsbc Global ResUpgradeHold
10/17/2024HSBCDowngradeBuy ➝ Hold$47.64
8/2/2024Robert W. BairdBoost TargetOutperform ➝ Outperform$47.64 ➝ $50.56
6/27/2024Wolfe ResearchUpgradePeer Perform ➝ Outperform$48.61
6/18/2024JPMorgan Chase & Co.Boost TargetOverweight ➝ Overweight$50.56 ➝ $52.50
5/1/2024Stifel NicolausLower TargetHold ➝ Hold$53.47 ➝ $43.75
2/16/2024Morgan StanleyUpgradeEqual Weight ➝ Overweight$48.11 ➝ $49.58
2/8/2024JPMorgan Chase & Co.Boost TargetOverweight ➝ Overweight$48.61 ➝ $50.56
2/8/2024CitigroupLower TargetBuy ➝ Buy$60.14 ➝ $58.33
12/20/2023JPMorgan Chase & Co.Boost TargetOverweight ➝ Overweight$45.10 ➝ $50.11
12/19/2023Wells Fargo & CompanyInitiated CoverageEqual Weight$44.10
12/13/2023Wolfe ResearchInitiated CoveragePeer Perform
12/7/2023The Goldman Sachs GroupUpgradeNeutral ➝ Buy$50.11
11/2/2023UBS GroupLower TargetNeutral ➝ Neutral$48.11 ➝ $42.10
10/17/2023JPMorgan Chase & Co.Lower TargetOverweight ➝ Overweight$55.13 ➝ $50.11
9/29/2023HSBCLower Target$64.15 ➝ $57.13
9/26/2023CitigroupReiterated RatingBuy ➝ Buy$60.14
9/11/2023Robert W. BairdInitiated CoverageOutperform$50.11
8/9/2023UBS GroupLower TargetNeutral ➝ Neutral$50.11 ➝ $48.11
5/23/2023Morgan StanleyUpgradeEqual Weight ➝ Overweight
5/5/2023UBS GroupLower Target$52.12 ➝ $50.11
2/9/2023UBS GroupBoost TargetNeutral$50.11 ➝ $52.12
2/9/2023CitigroupBoost TargetBuy$55.13 ➝ $60.14
11/11/2022Berenberg BankBoost Target€54.03 ➝ €54.73
11/9/2022CitigroupLower TargetBuy$62.14 ➝ $55.13
11/8/2022William BlairReiterated RatingMarket Perform
10/18/2022Morgan StanleyInitiated CoverageEqual Weight
10/10/2022Oddo BhfDowngradeOutperform ➝ Neutral
1/17/2022DZ BankUpgradeHold ➝ Buy
12/14/2021Wells Fargo & CompanyBoost TargetEqual Weight$58.13 ➝ $60.14
11/26/2021Kepler Capital MarketsDowngradeHold$49.11
10/21/2021Norddeutsche LandesbankReiterated RatingHold
10/14/2021Redburn PartnersInitiated CoverageBuy
7/14/2021CheuvreuxDowngradeBuy ➝ Hold$49.64
7/14/2021Kepler Capital MarketsDowngradeBuy ➝ Hold$49.64
7/14/2021CitigroupLower TargetBuy$65.15 ➝ $58.13
7/9/2021Kepler Capital MarketsUpgradeBuy$51.12
6/25/2021DZ BankReiterated RatingNeutral
6/17/2021Deutsche Bank AktiengesellschaftReiterated RatingBuy
6/11/2021Berenberg BankReiterated RatingBuy
6/8/2021The Goldman Sachs GroupReiterated RatingBuy
6/3/2021The Goldman Sachs GroupInitiated CoverageNeutral$52.12
5/4/2021Deutsche Bank AktiengesellschaftReiterated RatingBuy
4/22/2021Deutsche Bank AktiengesellschaftReiterated RatingBuy
4/7/2021DZ BankReiterated RatingNeutral
4/2/2021Kepler Capital MarketsReiterated RatingBuy
4/1/2021DZ BankReiterated RatingNeutral
2/19/2021Berenberg BankReiterated RatingBuy
2/17/2021Deutsche Bank AktiengesellschaftReiterated RatingBuy
2/10/2021Deutsche Bank AktiengesellschaftReiterated RatingBuy
1/6/2021Norddeutsche LandesbankReiterated RatingHold
1/6/2021Nord/LBReiterated RatingNeutral
12/14/2020DZ BankReiterated RatingSell
12/10/2020Exane BNP ParibasReiterated RatingOutperform
12/9/2020Deutsche Bank AktiengesellschaftReiterated RatingBuy
12/9/2020JPMorgan Chase & Co.Reiterated RatingBuy
11/26/2020Kepler Capital MarketsUpgradeBuy
11/11/2020DZ BankReiterated RatingSell
11/4/2020Berenberg BankReiterated RatingBuy
10/28/2020JPMorgan Chase & Co.Reiterated RatingBuy
10/6/2020Bank of AmericaUpgradeNeutral ➝ Buy$59.14
9/28/2020Kepler Capital MarketsUpgradeHold ➝ Buy$59.46
9/15/2020DZ BankReiterated RatingNeutral
8/30/2020Kepler Capital MarketsUpgradeHold
8/26/2020CommerzbankUpgradeHold ➝ Buy$66.15
8/24/2020CitigroupUpgradeNeutral ➝ Buy$48.11 ➝ $62.14
8/20/2020JPMorgan Chase & Co.Reiterated RatingOverweight$60.14
8/17/2020Wolfe ResearchInitiated CoverageMarket Perform$59.14
8/17/2020Berenberg BankUpgradeHold ➝ Buy
8/14/2020Exane BNP ParibasUpgradeNeutral ➝ Outperform
8/14/2020BNP ParibasUpgradeNeutral ➝ Outperform
8/14/2020Deutsche Bank AktiengesellschaftUpgradeHold ➝ Buy$32.07 ➝ $60.14
7/20/2020DZ BankReiterated RatingNeutral
7/14/2020DZ BankReiterated RatingNeutral
6/23/2020Warburg ResearchReiterated RatingHold ➝ Neutral
5/29/2020DZ BankReiterated RatingNeutral
5/6/2020Warburg ResearchReiterated RatingHold
4/2/2020Stifel NicolausBoost TargetHold$33.08 ➝ $40.09
3/25/2020Kepler Capital MarketsReiterated RatingHold
3/6/2020CfraBoost TargetHold$38.09 ➝ $42.10
3/4/2020Berenberg BankDowngradeBuy ➝ Hold
3/3/2020DZ BankReiterated RatingNeutral
(Data available from 2/16/2020 forward)

News Sentiment Rating

0.56 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 11 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/21/2024
  • 8 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/20/2024
  • 13 very positive mentions
  • 17 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
9/19/2024
  • 15 very positive mentions
  • 16 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
10/19/2024
  • 13 very positive mentions
  • 14 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
11/18/2024
  • 25 very positive mentions
  • 15 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/18/2024
  • 12 very positive mentions
  • 21 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/17/2025
  • 17 very positive mentions
  • 26 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
2/16/2025

Current Sentiment

  • 17 very positive mentions
  • 26 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
Qiagen logo
QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The firm assay technologies make these biomolecules visible and ready for analysis. Its bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996, and is headquartered in Venlo, the Netherlands.
Read More

Today's Range

Now: $39.85
Low: $39.69
High: $40.18

50 Day Range

MA: $43.54
Low: $39.35
High: $46.22

52 Week Range

Now: $39.85
Low: $39.27
High: $49.30

Volume

1,362,801 shs

Average Volume

1,330,707 shs

Market Capitalization

$8.84 billion

P/E Ratio

110.97

Dividend Yield

N/A

Beta

0.36

Frequently Asked Questions

What sell-side analysts currently cover shares of Qiagen?

The following Wall Street analysts have issued reports on Qiagen in the last year: Hsbc Global Res, HSBC Holdings plc, Jefferies Financial Group Inc., JPMorgan Chase & Co., Morgan Stanley, Robert W. Baird, Stifel Nicolaus, UBS Group AG, and Wolfe Research.
View the latest analyst ratings for QGEN.

What is the current price target for Qiagen?

0 Wall Street analysts have set twelve-month price targets for Qiagen in the last year. Their average twelve-month price target is $48.78, suggesting a possible upside of 22.4%. JPMorgan Chase & Co. has the highest price target set, predicting QGEN will reach $52.50 in the next twelve months. Stifel Nicolaus has the lowest price target set, forecasting a price of $43.75 for Qiagen in the next year.
View the latest price targets for QGEN.

What is the current consensus analyst rating for Qiagen?

Qiagen currently has 5 hold ratings and 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in QGEN, but not buy more shares or sell existing shares.
View the latest ratings for QGEN.

What other companies compete with Qiagen?

How do I contact Qiagen's investor relations team?

Qiagen's physical mailing address is HULSTERWEG 82, VENLO P7, 5912. The company's listed phone number is (177) 355-6600 and its investor relations email address is [email protected]. The official website for Qiagen is www.qiagen.com. Learn More about contacing Qiagen investor relations.